Kelly K. Wingfield

Kelly K. Wingfield

Auto-generated profile, based on publicly available information

Kelly K. Wingfield

Boston University Chobanian & Avedisian School of Medicine

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
EBErica Brunelle
Erica Brunelle
ALAnh Minh Le
Anh Minh Le
CHCrystal Huynh
Crystal Huynh
KWKelly Wingfield
Kelly Wingfield
Lenka HalamkovaLenka Halamkova
Lenka Halamkova
JHJan Halamek
Jan Halamek

27 September 2023 in Neuropharmacology
Verified
Journal Article
Closed access
KBKristyn N. Borrelli
Kristyn N. Borrelli
KWKelly K. Wingfield
Kelly K. Wingfield
EYEmily J. Yao
Emily J. Yao
CZCatalina A. Zamorano
Catalina A. Zamorano
KSKatherine D. Sena
Katherine D. Sena
CBCamron D. Bryant
Camron D. Bryant

7 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
KBKristyn N. Borrelli
Kristyn N. Borrelli
KWKelly K. Wingfield
Kelly K. Wingfield
EYEmily J. Yao
Emily J. Yao
CZCatalina A. Zamorano
Catalina A. Zamorano
KSKatherine D. Sena
Katherine D. Sena
CBCamron D. Bryant
Camron D. Bryant
Prenatal opioid exposure is a major health concern in the United States, with the incidence of neonatal opioid withdrawal syndrome (NOWS) escalating in recent years. NOWS occurs upon cessation of in utero opioid exposure and is characterized by increased irritability, disrupted sleep patterns, high-pitched crying, and dysregulated feeding. The main pharmacological strategy for alleviating symptoms is treatment with replacement opioids. The neural mechanisms mediating NOWS and the long-term neurobehavioral effects are poorly understood. We used a third trimester-approximate model in which neonatal outbred pups (Carworth Farms White; CFW) were administered once-daily morphine (15 mg/kg, s.c.) from postnatal day (P) day 1 through P14 and were then assessed for behavioral and transcriptomic adaptations within the nucleus accumbens (NAc) on P15. We also investigated the long-term effects of perinatal morphine exposure on adult learning and reward sensitivity. We observed significant weight deficits, spontaneous thermal hyperalgesia, and altered ultrasonic vocalization (USV) profiles following repeated morphine and during spontaneous withdrawal. Transcriptome analysis of NAc from opioid-withdrawn P15 neonates via bulk mRNA sequencing identified an enrichment profile consistent with downregulation of myelin-associated transcripts. Despite the neonatal behavioral and molecular effects, there were no significant long-term effects of perinatal morphine exposure on adult spatial memory function in the Barnes Maze, emotional learning in fear conditioning, or in baseline or methamphetamine-potentiated reward sensitivity as measured via intracranial self-stimulation. Thus, the once daily third trimester-approximate exposure regimen, while inducing NOWS model traits and significant transcriptomic effects in neonates, had no significant long-term effects on adult behaviors. HIGHLIGHTS: We replicated some NOWS model traits via 1x-daily morphine (P1-P14). We found a downregulation of myelination genes in nucleus accumbens on P15. There were no effects on learning/memory or reward sensitivity in adults.

15 June 2025 in Addiction Neuroscience
Verified
Journal Article
Open access
KWKelly K. Wingfield
Kelly K. Wingfield
TMTeodora Misic
Teodora Misic
SMSophia A. Miracle
Sophia A. Miracle
CMCarly S. McDermott
Carly S. McDermott
KJKaahini Jain
Kaahini Jain
CBCamron D. Bryant
Camron D. Bryant

4 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KWKelly K. Wingfield
Kelly K. Wingfield
TMTeodora Misic
Teodora Misic
KJKaahini Jain
Kaahini Jain
CMCarly S. McDermott
Carly S. McDermott
NANalia M. Abney
Nalia M. Abney
CBCamron D. Bryant
Camron D. Bryant
Rationale: Opioid use during pregnancy can lead to negative infant health outcomes, including neonatal opioid withdrawal syndrome (NOWS). NOWS comprises gastrointestinal, autonomic nervous system, and neurological dysfunction that manifest during spontaneous withdrawal. Variability in NOWS severity necessitates a more individualized treatment approach. Ultrasonic vocalizations (USVs) in neonatal mice are emitted in isolation as a stress response and are increased during opioid withdrawal, thus modeling a negative affective state that can be utilized to test new treatments. Objectives: We sought to identify the behavioral and USV profile, brainstem transcriptomic adaptations, and role of kappa opioid receptors in USVs during neonatal opioid withdrawal. Methods: We employed a third trimester-approximate opioid exposure model, where neonatal inbred FVB/NJ pups were injected twice-daily with morphine (10mg/kg, s.c.) or saline (0.9%, 20 ul/g, s.c.) from postnatal day(P) 1 to P14. This protocol induces reduced weight gain, hypothermia, thermal hyperalgesia, and increased USVs during spontaneous morphine withdrawal. Results: On P14, there were increased USV emissions and altered USV syllables during withdrawal, including an increase in Complex 3 syllables in FVB/NJ females (but not males). Brainstem bulk mRNA sequencing revealed an upregulation of the kappa opioid receptor ( Oprk1) , which contributes to withdrawal-induced dysphoria. The kappa opioid receptor (KOR) antagonist, nor-BNI (30 mg/kg, s.c.), significantly reduced USVs in FVB/NJ females, but not males during spontaneous morphine withdrawal. Furthermore, the KOR agonist, U50,488h (0.625 mg/kg, s.c.), was sufficient to increase USVs on P10 (both sexes) and P14 (females only) in FVB/NJ mice. Conclusions: We identified an elevated USV syllable, Complex 3, and a female-specific recruitment of the dynorphin/KOR system in increased USVs associated with neonatal opioid withdrawal severity.

7 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KWKelly K. Wingfield
Kelly K. Wingfield
TMTeodora Misic
Teodora Misic
SMSophia A. Miracle
Sophia A. Miracle
CMCarly S. McDermott
Carly S. McDermott
KJKaahini Jain
Kaahini Jain
CBCamron D. Bryant
Camron D. Bryant
Concomitant with the opioid epidemic, there has been a rise in pregnant women diagnosed with opioid use disorder and cases of infants born with neonatal opioid withdrawal syndrome (NOWS). NOWS refers to signs and symptoms following cessation of prenatal opioid exposure that comprise neurological, gastrointestinal, and autonomic system dysfunction. A critical indicator of NOWS severity is excessive, high-pitched crying. However, NOWS evaluation is, in large part, subjective, and additional cry features may not be easily recognized during clinical assessment. Thus, there is a need for more objective measures to determine NOWS severity. We used a third trimester-approximate opioid exposure paradigm to model NOWS traits in genetically similar inbred substrains of FVB/N mice (NJ, NCrl, NHsd, and NTac). Pups were injected twice daily from postnatal day 1 (P1) to P14 with morphine (10 mg/kg, s.c.) or saline (20 ml/g, s.c.). Because there were only very minor substrain differences in spontaneous withdrawal-induced ultrasonic vocalization (USV) profiles, we collapsed across substrains to evaluate the effects of morphine withdrawal on additional USV properties. We identified syllable sequences unique to morphine-withdrawn and saline-control FVB/N pups on P7 and P14. We also observed an effect of spontaneous morphine withdrawal on the acoustic properties of USVs and specific syllables on P7 and P14. Multiple withdrawal traits correlated with some acoustic properties of USVs and syllable type emission in morphine-withdrawn FVB/N pups on P7 and P14. These data provide an in-depth investigation of mouse USV syllable profiles and acoustic features during spontaneous neonatal opioid withdrawal in mice.